{"entity":{"id":"antonio-gonzalez-martin","kind":"person","name":"Antonio González-Martín","aka":[],"tldr":"Gynaecological medical oncologist directing the Cancer Center Clínica Universidad de Navarra; led the PRIMA trial of niraparib maintenance in ovarian cancer.","summary":"Antonio González-Martín is Director of the Cancer Center Clínica Universidad de Navarra (CCUN) and Co-Director of its Department of Medical Oncology. He is a leading gynaecological oncologist who served as principal investigator of the PRIMA/ENGOT-OV26 trial establishing niraparib first-line maintenance in advanced ovarian cancer, and has been president of the Spanish Ovarian Cancer Research Group (GEICO).","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://cancercenter.cun.es/cancer-center/organigrama"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gonzalez-Martin+A%5BAuthor%5D+ovarian"}],"tags":["leadership","clinician-scientist","ovarian cancer","gynaecological oncology"],"related":[],"cancers":["ovarian","endometrial","cervical"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["cun-navarra"],"pathways":[],"terms":[],"trials":["prima","beatcc"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director, Cancer Center Clínica Universidad de Navarra","institutionId":"cun-navarra","specialisms":["Medical oncology","Ovarian cancer","Gynaecological oncology"],"profiles":[{"label":"Institution profile","url":"https://cancercenter.cun.es/cancer-center/organigrama"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gonzalez-Martin+A%5BAuthor%5D+ovarian"}],"papers":[{"title":"Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","journal":"New England Journal of Medicine","year":2019,"doi":"10.1056/nejmoa1910962"},{"title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","journal":"Annals of Oncology","year":2023,"doi":"10.1016/j.annonc.2023.07.011"},{"title":"Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer","journal":"New England Journal of Medicine","year":2016,"doi":"10.1056/nejmoa1611310"}]},"route":"/people/antonio-gonzalez-martin/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"institution":[{"id":"cun-navarra","kind":"institution","name":"Cancer Center Clínica Universidad de Navarra / CIMA","route":"/institutions/cun-navarra/"}],"trial":[{"id":"beatcc","kind":"trial","name":"BEATcc / ENGOT-Cx10 / GOG-3030","route":"/trials/beatcc/"},{"id":"prima","kind":"trial","name":"PRIMA / ENGOT-OV26","route":"/trials/prima/"}]}}